Aspira Labs to Evaluate GenomeSmart Genetic Test Recommendation Platform

GenomeBrain uses artificial intelligence to match a person’s personal and medical history, as well as ethnicity and age, with national guidelines to recommended medically actionable genetic tests. The platform then generates a report that clinicians and their patients can use to determine a testing plan, according to Los Altos, California-based GenomeSmart.

Aspira, a subsidiary of Austin, Texas-based Vermillion, will offer GenomeBrain to a select group of its customers to improve the identification of patients who are at risk for hereditary cancer or passing hereditary diseases to their children. Participating healthcare providers will incorporate the platform into their current patient workflows to evaluate its effectiveness and ease of use.

Source: https://www.genomeweb.com/molecular-diagnostics/aspira-labs-evaluate-genomesmart-genetic-test-recommendation-platform